
Global CDMO with specialized peptide capabilities through Snapdragon Chemistry acquisition. Waltham, MA facility offers custom peptide synthesis using SPPS and innovative LPPS (liquid phase peptide synthesis) technology that reduces solvent demand. Expanded in 2025 with new cGMP manufacturing suite including ISO-7 cleanroom for prep HPLC and lyophilization. Part of Cambrex's broader network of 2,000+ experts across North America and Europe.
Claim this listing to update your information, respond to buyer inquiries, and get a verified badge.
Free to claim. Verified upgrades available.